UBS Group’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-258,184
| Closed | -$2.32M | – | 8605 |
|
|
2018
Q2 | $2.32M | Sell |
258,184
-2,305,938
| -90% | -$20.7M | ﹤0.01% | 3034 |
|
|
2018
Q1 | $23.5M | Buy |
2,564,122
+2,558,646
| +46,725% | +$23.7M | 0.01% | 1040 |
|
|
2017
Q4 | $53K | Buy |
5,476
+1,376
| +34% | +$10.2K | ﹤0.01% | 5807 |
|
|
2017
Q3 | $28K | Buy |
4,100
+976
| +31% | +$8.31K | ﹤0.01% | 6225 |
|
|
2017
Q2 | $36K | Sell |
3,124
-2,653
| -46% | -$26.2K | ﹤0.01% | 5897 |
|
|
2017
Q1 | $48K | Sell |
5,777
-9,705
| -63% | -$76K | ﹤0.01% | 5558 |
|
|
2016
Q4 | $122K | Sell |
15,482
-35,412
| -70% | -$291K | ﹤0.01% | 5155 |
|
|
2016
Q3 | $520K | Sell |
50,894
-8,592
| -14% | -$95.4K | ﹤0.01% | 3902 |
|
|
2016
Q2 | $671K | Buy |
59,486
+5,253
| +10% | +$65.8K | ﹤0.01% | 3683 |
|
|
2016
Q1 | $670K | Sell |
54,233
-3,057
| -5% | -$31.7K | ﹤0.01% | 3563 |
|
|
2015
Q4 | $682K | Sell |
57,290
-19,904
| -26% | -$258K | ﹤0.01% | 3705 |
|
|
2015
Q3 | $1.22M | Buy |
77,194
+3,598
| +5% | +$72.8K | ﹤0.01% | 3178 |
|
|
2015
Q2 | $1.49M | Buy |
73,596
+8,241
| +13% | +$189K | ﹤0.01% | 3257 |
|
|
2015
Q1 | $1.55M | Buy |
65,355
+11,280
| +21% | +$229K | ﹤0.01% | 3163 |
|
|
2014
Q4 | $983K | Buy |
+54,075
| New | +$1.07M | ﹤0.01% | 3580 |
|
UBS Group's KND Position: Q3 2018 in Review
UBS Group sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 258,184 shares — an estimated $2.32M sold.
UBS Group first reported a position in KND in Q4 2014 and held it in 15 quarters. The position peaked at $23.5M in Q1 2018. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- UBS Group reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- UBS Group sold 258,184 Kindred Healthcare shares in Q3 2018, an estimated $2.32M.
- UBS Group first reported a position in Kindred Healthcare in Q4 2014 and held it in 15 quarters.
- UBS Group's Kindred Healthcare position peaked at $23.5M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on UBS Group's 13F filing for Q3 2018, filed 14 Nov 2018.